OCT 18, 2020 7:55 PM PDT

Virus-Mimicking Drug

WRITTEN BY: Nouran Amin

Scientists have found drug that a drug activates the body’s immune system by behaving like a virus and may make certain tumors visible to the body’s defense system—such approach is known as targeted immunotherapy.

"Most immunotherapy approaches rely on the ability of T cells to recognize and kill tumor cells," said lead and corresponding author Dr. Anusha Kalbasi, an assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and member of the Jonsson Cancer Center. "But in some patients, tumors escape the immune system through mutations in genes involved in the interferon signaling pathway. This is a critical pathway because it normally allows tumors to increase their antigen presentation, an intricate machinery that makes tumors visible to T cells."

Findings were published in the journal Science Translational Medicine and discusses the possibility of using drugs to mimic viruses to overcome immunotherapy resistance in tumors with defective cellular signaling. Once such signal is interferons which slows down cell division in tumors and recruits more immune cells

"This coordinated effort as a result of interferon signaling can help the immune system better identify and kill tumor cells," Kalbasi said.

"This study helps us understand the interdependence between interferon signaling and antigen presentation, which gives us important insights into how tumor cells are recognized by the immune system," said the study's senior author, Dr. Antoni Ribas, a professor of medicine at the Geffen School of Medicine and director of the tumor immunology program at the Jonsson Cancer Center. "New strategies to promote antigen presentation to make tumors more visible to the immune system will allow immunotherapy to be effective for even more tumor types."

Learn more about immunotherapies:

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JAN 24, 2021
Cannabis Sciences
Cannabis Compound CBD Shows Promise as Antibiotic
JAN 24, 2021
Cannabis Compound CBD Shows Promise as Antibiotic
Researchers from the University of Queensland, in collaboration with Botanix Pharmaceuticals Limited, have found that ca ...
JAN 27, 2021
Drug Discovery & Development
Researchers Discover How LSD Encourages Prosocial Behavior
JAN 27, 2021
Researchers Discover How LSD Encourages Prosocial Behavior
Researchers from McGill University have discovered one of the possible mechanisms by which lysergic acid diethylamide (L ...
FEB 12, 2021
Drug Discovery & Development
Compound Reverses ALS Neuron Damage
FEB 12, 2021
Compound Reverses ALS Neuron Damage
Scientists at Northwestern University identify the first compound that removes the ongoing degeneration of upper motor n ...
MAR 09, 2021
Cannabis Sciences
Top Benefits of Having Your Medical Marijuana Card
MAR 09, 2021
Top Benefits of Having Your Medical Marijuana Card
With the use of medicinal marijuana booming, estimated at almost 4.5 million patients in 2020, it’s time to talk a ...
MAR 04, 2021
Infographics
All You Need to Know about COVID-19 Vaccines
MAR 04, 2021
All You Need to Know about COVID-19 Vaccines
After over a year lockdowns brought on by the pandemic, hopes for returning to something even similar to ' ...
MAY 06, 2021
Cannabis Sciences
New CBD Analog Outperforms Regular CBD for Pain Relief
MAY 06, 2021
New CBD Analog Outperforms Regular CBD for Pain Relief
Researchers from Temple University Health System have found that a novel cannabidiol (CBD) analog can reverse pain sensi ...
Loading Comments...